Hardman Johnston Global Advisors’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $6.84M | Buy |
+17,588
| New | +$6.84M | 0.3% | 46 |
|
2025
Q1 | – | Sell |
-20,020
| Closed | -$7.39M | – | 76 |
|
2024
Q4 | $7.39M | Sell |
20,020
-1,138
| -5% | -$420K | 0.3% | 49 |
|
2024
Q3 | $11M | Buy |
21,158
+18
| +0.1% | +$9.36K | 0.43% | 44 |
|
2024
Q2 | $11.5M | Sell |
21,140
-402
| -2% | -$218K | 0.44% | 44 |
|
2024
Q1 | $11.2M | Sell |
21,542
-1,208
| -5% | -$626K | 0.39% | 46 |
|
2023
Q4 | $10.7M | Sell |
22,750
-18
| -0.1% | -$8.49K | 0.34% | 49 |
|
2023
Q3 | $9.91M | Sell |
22,768
-558
| -2% | -$243K | 0.33% | 49 |
|
2023
Q2 | $10.4M | Buy |
23,326
+2,626
| +13% | +$1.17M | 0.34% | 51 |
|
2023
Q1 | $9.52M | Hold |
20,700
| – | – | 0.31% | 51 |
|
2022
Q4 | $10.6M | Buy |
20,700
+274
| +1% | +$141K | 0.42% | 47 |
|
2022
Q3 | $9.28M | Buy |
+20,426
| New | +$9.28M | 0.42% | 47 |
|